Article

Missing topics at SABCS

Author(s):

The first slide from every presenter at the San Antonio Breast Cancer Symposium indicates whether they have any conflict of interest, which translated into English means whether they are getting paid by a pharmaceutical company or anyone else for anything.Last night at the symptom management educational session, which was packed, the speaker's slide said something to the effect that her topic, lymphedema and weight lifting, did not involve a drug and therefore was of no interest to anyone, so she had no conflict of interest. In other words, there would be no profit involved in what she did, except maybe for a few scattered personal trainers and the gyms where they work.I think I might be getting jaded around the edges. I look at the presentations here and see lots of really complicated topics involving the use of drugs in every conceivable way. But in the midst of all these presentations, where are the researchers who are looking at prevention and the mechanisms that make a cell go haywire in the first place? Where are the studies on the issues that make it possible to live with, through and in spite of breast cancer? These are issues such as depression, pain, sexuality, fatigue and fear. Barbara Anderson's work showed clearly that stress reduction reduced recurrence by 20 percent. If that was a drug, it would be international headlines.I don't want to malign research because I know it's critical, but can we make room for some of the other issues that are so critical to women living through breast cancer? Yesterday in Project LEAD, the opening speaker used a statistic to show how far we have come by noting that there were around 12,300 papers on breast cancer published in 2009 compared to more than 24,000 in 2010. I thought that sounded amazing until the next speaker from the National Breast Cancer Coalition asked whether that was a positive or a negative. Are we rewarding the right thing? Should papers and patents (read money) be the goal?As a former academic, I know firsthand the importance placed on publishing. It is the standard by which teachers are measured. The same is true for researchers. They get funds, their institutions get publicity, and women, sometimes, get the results.Let's celebrate those researchers and make room for studies on quality of life and survivorship.

Related Videos
1 expert is featured in this series.
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Bald Doctor.
Dr. David A. Braun, an Assistant Professor of Medicine, Medical Oncology, and a Louis Goodman and Alfred Gilman Yale Scholar, at the Yale School of Medicine, as well as a member of the Center of Molecular and Cellular Oncology at Yale Cancer Center, in New Haven, Connecticut
1 expert is featured in this series.
Dr. Anna Arthur is the Director of the Medical Nutrition Science Program, as well as a tenure-track Assistant Professor in the Department of Dietetics and Nutrition at the University of Kansas Medical Center.
Dr. Ritu Salani, the Director of Gynecologic Oncology at the University of California, Los Angeles (UCLA), UCLA Health, and a board-certified gynecologic oncologist.
Image of Dr. Scott Kopetz
Image of Dr. Susumu Hijoka
1 expert is featured in this series.